Cargando…
Personalised prevention of type 2 diabetes
It is well established from clinical trials that behavioural interventions can halve the risk of progression from prediabetes to type 2 diabetes but translating this evidence of efficacy into effective real-world interventions at scale is an ongoing challenge. A common suggestion is that future prev...
Autor principal: | Wareham, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9522721/ https://www.ncbi.nlm.nih.gov/pubmed/35916901 http://dx.doi.org/10.1007/s00125-022-05774-7 |
Ejemplares similares
-
Personalised Prophylaxis in a Child with Haemophilia A and Type 1 Diabetes
por: Cruz, Maria Sol, et al.
Publicado: (2021) -
Towards salutogenesis in the development of personalised and preventive healthcare
por: Alivia, Mauro, et al.
Publicado: (2011) -
Personalised medicine in asthma: from curative to preventive medicine
por: Guilleminault, Laurent, et al.
Publicado: (2017) -
Digital Health in Focus of Predictive, Preventive and Personalised Medicine
por: Mszar, Reed
Publicado: (2021) -
Metabolomic biomarkers for personalised glucose lowering drugs treatment in type 2 diabetes
por: den Ouden, Henk, et al.
Publicado: (2016)